Showing results (1-10 of 300) with videos related to
Sort By:
Pageof 30
Molecular Urology|November 4, 2000
Neoadjuvant hormone therapy: the Canadian trialsL Klotz, M Gleave, S L GoldenbergProstate Cancer and Prostatic Diseases|December 24, 2002
Intermittent androgen suppression for prostate cancer: rationale and clinical experienceM Gleave, S L Goldenberg, N Bruchovsky, et al.European Urology|December 17, 1998
Intermittent androgen suppression for prostate cancer: rationale and clinical experienceM Gleave, N Bruchovsky, S L Goldenberg, et al.Der Urologe. Ausg. A|September 1, 1995
[Theoretical considerations and initial clinical results of intermittent hormone treatment of patients with advanced prostatic carcinoma]N Bruchovsky, S L Goldenberg, P S Rennie, et al.Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 1, 1996
[Hormone release and intermittent hormonal therapy in the LN CaP model of human prostate cancer]M Gleave, N Santo, P S Rennie, et al.The Journal of Urology|October 12, 2000
A randomized phase 3 study of intraoperative cavernous nerve stimulation with penile tumescence monitoring to improve nerve sparing during radical prostatectomyL Klotz, J Heaton, M Jewett, et al.Canadian Family Physician Medecin De Famille Canadien|January 15, 2011
Advances in diagnosis and management of prostate cancerS L GoldenbergBJU International|November 9, 2000
Placebo-associated remissions in a multicentre, randomized, double-blind trial of interferon gamma-1b for the treatment of metastatic renal cell carcinoma. The Canadian Urologic Oncology GroupM M Elhilali, M Gleave, Y Fradet, et al.Seminars in Urologic Oncology|March 17, 2000
Neurostimulation during radical prostatectomy: improving nerve-sparing techniquesL KlotzPageof 30